| Literature DB >> 31319636 |
Muhammed Walugembe1, James R Mushi2, Esinam N Amuzu-Aweh3, Gaspar H Chiwanga2, Peter L Msoffe2, Ying Wang4, Perot Saelao4, Terra Kelly4,5, Rodrigo A Gallardo5, Huaijun Zhou4, Susan J Lamont1, Amandus P Muhairwa6, Jack C M Dekkers7.
Abstract
Newcastle Disease (ND) is a continuing global threat to domestic poultry, especially in developing countries, where severe outbreaks of velogenic ND virus (NDV) often cause major economic losses to households. Local chickens are of great importance to rural family livelihoods through provision of high-quality protein. To investigate the genetic basis of host response to NDV, three popular Tanzanian chicken ecotypes (regional populations) were challenged with a lentogenic (vaccine) strain of NDV at 28 days of age. Various host response phenotypes, including anti-NDV antibody levels (pre-infection and 10 days post-infection, dpi), and viral load (2 and 6 dpi) were measured, in addition to growth rate. We estimated genetic parameters and conducted genome-wide association study analyses by genotyping 1399 chickens using the Affymetrix 600K chicken SNP chip. Estimates of heritability of the evaluated traits were moderate (0.18-0.35). Five quantitative trait loci (QTL) associated with growth and/or response to NDV were identified by single-SNP analyses, with some regions explaining ≥1% of genetic variance based on the Bayes-B method. Immune related genes, such as ETS1, TIRAP, and KIRREL3, were located in regions associated with viral load at 6 dpi. The moderate estimates of heritability and identified QTL indicate that NDV response traits may be improved through selective breeding of chickens to enhance increased NDV resistance and vaccine efficacy in Tanzanian local ecotypes.Entities:
Keywords: GWAS; NDV; QTL; Tanzanian local ecotypes; immune response
Year: 2019 PMID: 31319636 PMCID: PMC6678660 DOI: 10.3390/genes10070546
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Genotype quality metrics provided by Affymetrix and the requirements used in quality control filtering.
| Affymetrix Genotype Metric | Metric Description | Requirement |
|---|---|---|
| Nclus | Number of genotype clusters | ≥2 |
| CR | % of samples with genotype call other than "No call" for SNP | ≥99% |
| MinorAlleleFrequency | Min (PA, PB), where PA is frequency of Allele A, and PB = 1−PA | ≥0.05 |
| FLD | Measure of the cluster quality of a probeset | ≥5.12 |
| HomRO | Distance to zero in the Contrast dimension (X position) from the center of the homozygous cluster that is closest to zero | ≥0.47 |
| HomFLD | Version of FLD computed for the homozygous genotype clusters | ≥13.34 |
| HetSO | Measures how far the heterozygous cluster center sits above the homozygous cluster centers in the Size dimension (Y position) | ≥−0.35 |
| ConversionType | Probeset classification | ≠OTV |
| BB.varX | Contrast (X position) variance for BB cluster | ≤0.85 |
| BB.varY | Size (Y position) variance for BB cluster | ≤0.69 |
| AB.varX | Contrast (X position) variance for AB cluster | ≤0.75 |
| AB.varY | Size (Y position) variance for AB cluster | ≤0.78 |
| AA.varX | Contrast (X position) variance for AA cluster | ≤0.79 |
| AA.varY | Size (Y position) variance for AA cluster | ≤0.51 |
Figure 1The admixture plot showing mixed ancestry among individuals for the three populations. ecotypes; Ching, Kuchi and MoroMid.
Figure 2Multi-dimensional scaling (MDS) plot showing the three sampled population ecotypes.
Trait statistics and estimates (±SE) of variance components from univariate analyses.
| Trait | N3 | Mean4 | SD5 | Heritability + SE | Maternal6 | Residual |
|---|---|---|---|---|---|---|
| Pre-infection GR1 | 1392 | 5.12 | 1.31 | 0.35 ± 0.07 | 0.02 | 0.80 ± 0.06 |
| Post-infection GR1 | 1359 | 6.85 | 2.82 | 0.21 ± 0.06 | - | 3.83 ± 0.24 |
| Antibody titer2 | 1394 | 3.45 | 0.45 | 0.22 ± 0.05 | - | 0.13 ± 0.01 |
| VL2dpi2 | 1375 | 4.72 | 1.03 | 0.18 ± 0.07 | 0.06 | 0.49 ± 0.03 |
| VL6dpi2 | 1365 | 4.25 | 1.18 | 0.29 ± 0.06 | - | 0.66 ± 0.05 |
| Viral clearance | 1342 | 0.06 | 0.68 | 0.04 ± 0.01 | - | 0.41 ± 0.02 |
1Growth rate (g/day), 2log10 transformation, dpi = day post infection, VL = Viral Load 3Number of phenotypic records, 4Arithmetic mean, 5 Phenotypic SD from the ASREML analyses, 6 Variance due to dam as a proportion of phenotypic variance, Viral clearance = (Log10VL2dpi − Log10VL6dpi)/Log10VL2dpi.
Estimates (± SE) of genetic (above diagonal) and phenotypic (below diagonal) correlations based on bivariate analyses.
| Pre-Infection GR3 | Post-Infection GR | Antibody | VL2dpi | VL6dpi | Viral Clearance | |
|---|---|---|---|---|---|---|
| Pre-infection GR1 | 0.74 ± 0.08 | 0.24 ± 0.14 | −0.06 ± 0.14 | −0.23 ± 0.13 | 0.29 ± 0.20 | |
| Post-infection GR1 | 0.54 ± 0.02 | 0.26 ± 0.15 | 0.02 ± 0.17 | −0.13 ± 0.16 | 0.15 ± 0.23 | |
| Antibody2 | 0.16 ± 0.03 | 0.06 ± 0.03 | 0.07 ± 0.17 | −0.04 ± 0.14 | 0.30 ± 0.21 | |
| VL2dpi2 | −0.05 ± 0.03 | −0.07 ± 0.03 | 0.10 ± 0.03 | 0.17 ± 0.15 | 0.06 ± 0.23 | |
| VL6dpi2 | −0.14 ± 0.03 | −0.13 ± 0.03 | 0.03 ± 0.03 | 0.09 ± 0.03 | −0.11 ± 0.21 | |
| Viral Clearance | 0.04 ± 0.03 | 0.01 ± 0.03 | 0.04 ± 0.03 | 0.18 ± 0.03 | −0.29 ± 0.03 |
1 Growth rate, 2 log10 transformation, dpi = day post infection, VL = Viral Load. Viral clearance = (Log10Viral load, 2dpi − Log10Viral load, 6dpi)/Log10Viral load, 2dpi. 3Average daily gain.
Single nucleotide polymorphisms (SNPs) associated with NDV response traits based on genome-wise significance and positional candidate genes.
| Trait | SNP | Position | Candidate Genes and Location | |
|---|---|---|---|---|
| Pre-infection_GR | AX-76523043 | 3:63366122 | 5.42 × 10−6 | GOPC, downstream, 4697 |
| AX-76262097 | 22:1854894 | 6.75 × 10−6 | ||
| Post-infection_GR | AX-75920682 | 19:1607256 | 3.65 × 10−6 | AUTS2, intron |
| Antibody | AX-76035154 | 2:145809151 | 6.43 × 10−6 | RPLP1, upstream, 3167 |
| AX-77135791 | 9: 14444877 | 9.66 × 10−6 | ||
| Log10Viral load, 2dpi | AX-76811433 | 5:28848641 | 5.88 × 10−6 | PLEKHH1, intron |
| Log10Viral load, 6dpi | AX-76312211 | 24:429611 | 2.25 × 10−9 | TIRAP, downstream, 9853 |
| AX-76312344 | 24:432457 | 6.16 × 10−9 | ||
| AX-76311970 | 24:424057 | 1.22 × 10−8 |
Percentage of genetic variance explained by 1-Mb genomic regions that are associated with NDV response traits (>0.5% of genetic variance) based on the Bayes-B method.
| Trait | Chr | Position Window (Mb) | #Markers | %TGV1 |
|---|---|---|---|---|
| Pre-infection GR | 22 | 1004589-1997368 | 509 | 1.15 |
| 4 | 71001596-71999395 | 287 | 0.93 | |
| 11 | 18001466-18991342 | 409 | 0.64 | |
| 12 | 11001448-11994345 | 485 | 0.63 | |
| 15 | 4000820-4999664 | 625 | 0.59 | |
| 3 | 63009968-63997299 | 322 | 0.58 | |
| 20 | 76150-998687 | 317 | 0.51 | |
| 3 | 65001841-65999833 | 377 | 0.5 | |
| 2 | 29005343-29996746 | 326 | 0.5 | |
| 1 | 140114736-140998169 | 292 | 0.5 | |
| Post-infection GR | 19 | 1000224-1999134 | 722 | 1.18 |
| 7 | 28002821-28999513 | 472 | 0.55 | |
| Antibody2 | 9 | 13000454-13998539 | 492 | 1.08 |
| 13 | 12000451-12999639 | 472 | 0.67 | |
| 14 | 10000304-10999961 | 635 | 0.65 | |
| 8 | 1000043-1999902 | 446 | 0.63 | |
| 30 | 48000483-48965385 | 175 | 0.56 | |
| 9 | 14001725-14997194 | 537 | 0.54 | |
| 10 | 2000005-2998892 | 581 | 0.54 | |
| Log10Viral load, 2dpi2 | 5 | 28000344-28996407 | 407 | 2 |
| 5 | 41000480-41998371 | 353 | 0.8 | |
| 9 | 5001289-5998634 | 519 | 0.51 | |
| 7 | 8003124-8997158 | 310 | 0.51 | |
| Log10Viral load, 6dpi2 | 24 | 7891-999869 | 740 | 12.4 |
| 30 | 21001186-21998289 | 341 | 0.71 | |
| 1 | 133002233-133996605 | 410 | 0.57 |
1 Percentage of total genetic variance, Traits log10 transformed.
Figure 3Manhattan plots showing the genome-wide association results for pre-infection growth rate using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) non-overlapping window of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and red lines indicate genome-wide significance at 1% genetic variance and 20% genome-wise significance.
Figure 4Manhattan plots showing the genome-wide association results for post-infection growth rate using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) nonoverlapping windows of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and reds lines indicate genome-wide significance at 1% genetic variance and 20% suggestive adjusted Bonferroni correction, respectively.
Figure 5Manhattan plots showing the genome-wide association results for antibody levels at 10 dpi using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) nonoverlapping windows of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and red lines indicate genome-wide significance at 1% genetic variance and 20% suggestive adjusted Bonferroni correction, respectively.
Figure 6Manhattan plots showing the genome-wide association results for viral load at 2 dpi using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) nonoverlapping windows of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and red lines indicate genome-wide significance at 1% genetic variance and 20% suggestive adjusted Bonferroni correction, respectively.
Figure 7Manhattan plots showing the genome-wide association results for viral load at 6 dpi using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) nonoverlapping windows of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and red lines indicate genome-wide significance at 1% genetic variance and 20% suggestive adjusted Bonferroni correction, respectively.
Figure 8Manhattan plots showing the genome-wide association results for viral clearance using Bayes-B and single-SNP analyses. (A) Bayes-B results show the percent of genetic variance explained by 1-Megabase (1-Mb) nonoverlapping windows of SNPs across chromosomes. (B) Single-SNP results show the −log10(p-value) of ordered SNPs across the chromosomes. The blue and red lines indicate genome-wide significance at 1% genetic variance and 20% suggestive adjusted Bonferroni correction, respectively.
Positions and genes located in 1 Mb windows with ≥1% of genetic variance for NDV response traits.
| Trait | # SNPs | Chr: Window (Mb) | Genes |
|---|---|---|---|
| Pre-infection_GR | 287 | 4: 71.00–72.0 | PCDH7 |
| 509 | 22: 1.00–2.0 | TNFRSF10B, NEFM, GFRA2, NKX2-6, XPO7, NEFL, TTI2, RHOBTB2, CHMP7, ADAM28, LOXL2, NKX3-1, DOK2, DMTN, LZTS1, SLC18A1, SLC39A14, STC1, MAK16, RNF122, DUSP26, ENTPD4, SLC25A37, DOCK5, ATP6V1B2, EGR3, PBDC1, PHYHIP, C8orf58, SORBS3, NPM2, POLR3D, BIN3, PPP3CC, PEBP4, R3HCC1, LOC107050771 | |
| Post_infection_GR | 722 | 19: 1.00–2.0 | AUTS2, WBSCR17, CALN1, TYW1, MIR1587, MIR1354, MIR1567 |
| Antibody | 492 | 9: 13.0–14.0 | UTS2B, FGF12, ATP13A4, OPA1, CCDC50, GMNC, GP5, LRRC15, OSTN, MB21D2, FCGBP, HRASLS, ATP13A5, CPN2, ATP13A3, HES1 |
| 2 dpi | 407 | 5: 28.0–29.0 | ACTN1, SLC39A9, ZFP36L1, SMOC1, SRSF5, EXD2, TMEM229B, ERH, CCDC177, RAD51B, DCAF5, GALNT16, PLEKHD1, SUSD6, MIR1710, MIR1617, SRSF5A, SLC10A1 |
| 6 dpi | 740 | 24: 0.0–1.0 | ETS1, CHEK1, H2AFX, CDON, PANX3, ST3GAL4, C2CD2L, FAM118B, STT3A, MSANTD2, SRPRA, VSIG10L2, ROBO3, RPUSD4, HYLS1, SIK2, HEPACAM, FEZ1, KIRREL3, DCPS, TIRAP, FOXRED1, PUS3, ESAM, CCDC15, SLC37A2, VPS11, HMBS, DPAGT1, PKNOX2, NRGN, MIR1758, EI24, TMEM218, ROBO4, SPA17, LOC112530272 |